Massively univariate regression and inference in the form of statistical parametric mapping have transformed the way in which multidimensional imaging data are studied. In functional and structural neuroimaging, the de facto standard "design matrix"-based general linear regression model and its multi-level cousins have enabled investigation of the biological basis of the human brain. With modern study designs, it is possible to acquire multiple three-dimensional assessments of the same individuals -e.g., structural, functional and quantitative magnetic resonance imaging alongside functional and ligand binding maps with positron emission tomography. Current statistical methods assume that the regressors are non-random. For more realistic multi-parametric assessment (e.g., voxel-wise modeling), distributional consideration of all observations is appropriate (e.g., Model II regression). Herein, we describe a unified regression and inference approach using the design matrix paradigm which accounts for both random and nonrandom imaging regressors.
Introduction
The strong relationship between structure and biological function holds true from the macroscopic scale of multi-cellular organisms to the nano scale of biomacromolecules. Experience informs the clinical researcher that such structurefunction relationships must also exist in the brain and, when discovered and quantified, will be powerful informers for early disease detection, prevention, and our overall understanding of the brain. Brain imaging modalities, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), are primary methods for investigating brain structure and function. Quantification of the structure function relationship using imaging data, however, has been challenging owing to the high-dimensional nature of the data and issues of multiple comparisons. X. Yang et al.
Statistical Parametric Mapping (SPM) enables exploration of relational hypotheses without a priori assumptions of regions of interest (ROIs) where the correlations would occur [1, 2] . SPM was limited to single modality regression with imaging data represented only in the regressand until extensions (e.g., Biological Parametric Mapping, BPM) were developed to enable multi-modality regression, allowing for imaging data to use considered for both regressors and regressand [3, 4] . These multimodal methods rely on the traditional ordinary least squares approach in which regressors are exactly known (i.e., conditional inference). Although this assumption may be reasonable in SPM, where scalar regressors are likely to have significantly less variance than the regressand imaging data, such an assumption is clearly violated when both regressors and regressand are observations from imaging data. With BPM inference is not inverse consistent; interchanging the regressors and regressand images would yield different estimates of relationships. The inconsistent inverse behavior of BPM is a result of violated mathematical assumptions, not underlying biological truths. A researcher is seeking to uncover the two way structure-function relationship and a mathematical technique that optimizes an inverse consistent mapping rather than a unidirectional mapping would bring estimates closer to modeling these underlying physical truths.
Regression analysis accounting for errors in regressors would greatly improve the credibility of the truth model whilst reasonably considering the randomness of the imaging modality. Statistical methods accounting for random regressors have been developed and are collectively known as Model II regression [5, 6] . Surprisingly, Model II regression has not been generalized for the massively univariate case. To more accurately reflect clinical imaging data, herein we develop a general model that accounts for both random regressors and non-random regressors for use in the context of BPM and multi-modality image regression.
Theory
Our aim is to explain the observed intensity from one imaging modality, y, with a set of regressors, x, of which at least one member is observed intensity from another imaging modality. We begin with a typical general linear model (GLM) and reformulate it to explicitly reflect the clinical imaging case of both random and nonrandom regressors. To begin, GLM is formulated as, ∑
where d is the total number of regressors, ε is a parameterization of observational error in y, and β is a vector of the fitted coefficients. Let and σ y represent the common variance of each element about its truth in x (l) and y respectively. Then the x (l) can be divided into two disjoint sets, fixed regressors whose values are considered to be exactly known, x f , s.t. ( << σ y ), and random regressors, x r , s.t. ( not << σ y ). In BPM, all regressors are treated as fixed regressors. By inclusion of random regressors, that Model-II diverges from BPM. Owing to their larger σ values, the observed x r are only therefore noisy estimates of the truth, x rT . Eq. 1 then becomes,
